Genes
Oligo Pools
NGS
Variant Libraries
Antibodies
IVDR Solutions
Get matched with an expert
Whether you’re looking for bespoke data configurations or help with complex contracting, our team is here to help.
Deploy the B-Body ® platform for rapid discovery and robust developability, without compromise.
De-risk and accelerate bispecific antibody development
Speed to candidate
Accelerate discovery, reformatting, and screening with integrated workflows and high-throughput testing.
Derisked development
Increase success rate from discovery to development by eliminating reformatting risks.
CMC-ready candidates
Produce bispecifics with industry-leading expression and streamlined purification.
Plug & play compatible
Robustly reformat new or existing antibodies. Easy-to-trial platform with flexible testing access.
Explore the platform
B-Body® Bispecifics: Ultimate flexibility
for confidence in clinic
The answer to common bispecific challenges like light chain mispairing, instability, and low yield. Ready to use in final format and scalable manufacturing.
B-Body® Bispecific
A premier bispecific antibody framework engineered for exceptional yield, purity, and stability.
Explore an innovative framework that is optimized for yield and performance
- Unmatched bispecific yield
- Validated production in multiple commercial stable cell lines
- Proper assembly for heterodimerization for simple CMC
- 95% single-pass purity on CH1 or Protein A
- High solubility, stability, and low viscosity for formulation
Fc Region
Heavy-chain pairing with clinically-validated knobs-into-hole format.
Improve purity and yield
Reduce heavy-chain homodimers to increase the proportion of correctly assembled bispecific molecules.
De-risk manufacturing
Efficient assembly with a widely adopted strategy in therapeutic antibody development.
Fab Arm A
Prevent light-chain mispairing with rationally engineered Fab heterodimer.
Leverage proprietary CH3 domains
Replace CH1/CL on one Fab arm, driving correct pairing and ensuring proper light chain assembly on arm A.
Fab Arm B
Enhanced bispecific expression and purification.
Fab swap
Full Fab arm swap with disulfide lock.
Simplify purification
A single CH1 domain as well as pI asymmetry enables efficient purification in high throughput as well as larger scales.
Sole CH1 Domain
A powerful purification step beyond standard protein A/IEX.
Enable one-step purification
Simplify downstream processing during characterization and screening with a sole CH1 domain that facilitates purification using an anti-CH1 resin.
Services
Support at every stage of your bispecific development
Antibody Discovery
Discover bispecific-ready antibodies from the start. Design campaigns that reduce downstream engineering and improve success rates.
Explore
Antibody Production and Characterization
Rapidly generate and test bispecific formats. Plug existing mAbs into high-throughput bispecific screening workflows.
Explore
Antibody Optimization
Advance developable bispecific candidates. Select candidates expressed directly in final format to streamline development.
ExploreLet data drive your decisions
99%
Compatibility
Reformatting success
~200mg/mL
Formulation
Without viscosity limitation
>10g/L
Expression
Yield in stable CHO production
12+
Biopharma licensees
B-Body Bispecific biologics
Partner companies using B-Body Bispecifics
Technical documents
Explore the B-Body platform in depth with these resources.
Product Sheets
B-Body Bispecific Platform Product SheetService Sheets
B-Body Bispecific Antibody Production Service SheetSlide Decks
B-Body Bispecific Antibody Discovery Capabilities and Case StudyFor Research Use Only.
Not for Diagnostic Procedures.
Twist Bioscience HQ
681 Gateway Blvd
South San Francisco, CA 94080
